Updated on 17 December 2015
Verb Surgical aims to develop a comprehensive surgical solutions platform
Singapore: Johnson & Johnson has formed an independent surgical solutions company, Verb Surgical, in collaboration with Verily Life Sciences (formerly Google Life Sciences).
The new company is formed in connection with the strategic collaboration between Ethicon, a Johnson & Johnson medical devices company, and Google Life Sciences, which was announced in March 2015. Mr Scott Huennekens, an experienced business leader with over 20 years in the medical device industry, has been appointed as Verb Surgical's President and CEO.
"We believe Verb Surgical has the potential to change the future of surgery, not just robotic surgery," said Mr Gary Pruden, worldwide chairman, Johnson & Johnson Medical Devices. "The team has already made meaningful progress on the robotics platform, which is being developed for application across a host of surgical specialties." Ethicon, which has deep expertise in minimally invasive surgery and advanced instrumentation, is developing surgical instruments for Verb Surgical's new robotics-assisted platform.
In the coming years, Verb Surgical aims to develop a comprehensive surgical solutions platform that will incorporate robotic capabilities and medical device technology for operating room professionals. The goal of Verb Surgical is to develop these new technologies in partnership with surgeons and hospitals to enable better patient outcomes, improve access to minimally invasive surgery, and achieve greater hospital efficiency.